US XPRESS ENTERPRISES INC -A (USX)

US90338N2027 - Common Stock

6.14  0 (0%)

After market: 6.14 0 (0%)

Fundamental Rating

1

USX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 36 industry peers in the Ground Transportation industry. USX may be in some trouble as it scores bad on both profitability and health. USX is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year USX has reported negative net income.
In the past year USX had a positive cash flow from operations.
In multiple years USX reported negative net income over the last 5 years.
In the past 5 years USX always reported a positive cash flow from operatings.

1.2 Ratios

USX has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

USX has a better Gross Margin (61.79%) than 72.50% of its industry peers.
USX's Gross Margin has declined in the last couple of years.
USX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.29%
GM growth 5Y-1.85%

0

2. Health

2.1 Basic Checks

USX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USX has been increased compared to 1 year ago.
Compared to 5 years ago, USX has more shares outstanding
Compared to 1 year ago, USX has a worse debt to assets ratio.

2.2 Solvency

USX has an Altman-Z score of 1.44. This is a bad value and indicates that USX is not financially healthy and even has some risk of bankruptcy.
USX has a Altman-Z score of 1.44. This is in the lower half of the industry: USX underperforms 72.50% of its industry peers.
USX has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.79, USX is doing worse than 67.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 1.44
ROIC/WACCN/A
WACC8.23%

2.3 Liquidity

USX has a Current Ratio of 0.71. This is a bad value and indicates that USX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of USX (0.71) is worse than 77.50% of its industry peers.
A Quick Ratio of 0.69 indicates that USX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.69, USX is doing worse than 72.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.69

3

3. Growth

3.1 Past

USX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1220.00%.
The Revenue has been growing slightly by 6.04% in the past year.
The Revenue has been growing slightly by 6.80% on average over the past years.
EPS 1Y (TTM)-1220%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-2450%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y8.17%
Revenue growth 5Y6.8%
Revenue growth Q2Q-4.73%

3.2 Future

Based on estimates for the next years, USX will show a very strong growth in Earnings Per Share. The EPS will grow by 47.15% on average per year.
Based on estimates for the next years, USX will show a small growth in Revenue. The Revenue will grow by 3.65% on average per year.
EPS Next Y11.56%
EPS Next 2Y47.89%
EPS Next 3Y47.15%
EPS Next 5YN/A
Revenue Next Year-2.35%
Revenue Next 2Y1.33%
Revenue Next 3Y3.65%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for USX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 52.11, USX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USX indicates a slightly more expensive valuation: USX is more expensive than 67.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.88, USX is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 52.11

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, USX is valued a bit more expensive than the industry average as 72.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.23

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as USX's earnings are expected to grow with 47.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.89%
EPS Next 3Y47.15%

0

5. Dividend

5.1 Amount

USX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

US XPRESS ENTERPRISES INC -A

NYSE:USX (6/30/2023, 7:04:00 PM)

After market: 6.14 0 (0%)

6.14

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap331.91M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.11
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 61.79%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1220%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y11.56%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.04%
Revenue growth 3Y8.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y